# Trial to Study the Adjuvant Benefits of Quercetin Phytosome in Patients With COVID-19

> **NCT04578158** · PHASE3 · COMPLETED · sponsor: **Liaquat University of Medical & Health Sciences** · enrollment: 152 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Standard COVID-19 care
- **DIETARY_SUPPLEMENT:** Quercetin Phytosome

## Key facts

- **NCT ID:** NCT04578158
- **Lead sponsor:** Liaquat University of Medical & Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-29
- **Primary completion:** 2021-03-28
- **Final completion:** 2021-04-15
- **Target enrollment:** 152 (ACTUAL)
- **Last updated:** 2021-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04578158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04578158, "Trial to Study the Adjuvant Benefits of Quercetin Phytosome in Patients With COVID-19". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04578158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*